About Solon Ventures
Solon Ventures is a venture capital firm founded in 2005. It is primarily based out of London, United Kingdom. As of Nov 2015, Solon Ventures has invested in 9 companies. It primarily invests in Series A round in United Kingdom based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Consumer and Life Sciences. Most recently it participated in the $***** Series B round of Fever Overall, Solon Ventures portfolio has seen 1 unicorn and 5 acquisitions including key companies like Fever, Xceleron and Prosonix. A lot of funds co-invest with Solon Ventures, with names like Frog Capital sharing a substantial percentage of its portfolio. Solon Ventures has team of 2 people including 2 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, PE & 2 more
Portfolio Unicorns
Solon Ventures' List of Top Investments
Solon Ventures has a portfolio of 9 companies, one of which is a Unicorn. Their most notable investmentis in OrgvueTheir portfolio spans across United Kingdom and United States. They have invested in Enterprise Applications, Consumer, Life Sciences and 3 other sectors, across stages such as Series A, PE and 2 more. Here is the list of top investments by Solon Ventures:
1. Fever
Operator of a platform for booking tickets to various events. The platform allows users to discover and book experiences such as concerts, festivals, immersive exhibits, and other cultural or recreational activities. Support is available via email, live chat, or phone.
Key facts about Fever
- Founded Year: 2014
- Location: New York City (United States)
- Valuation: $*****
- Stage: Series E
- Total Funding till date: $527M
- Employee Count: 5,153 as on Mar 31, 2026
- Investors: Fidelity Investments, Goldman Sachs and 24 Others
- Latest Funding Round: Series E, Jun 04, 2025, $*****
- Highlight: Editors' Pick
2. Orgvue
Cloud-based suite solutions for workforce analytics. The platform offers tools for data management, activity analysis, data visualization, scenario modelling, etc. The platform allows users to provide work to the candidate based on skills, performance and availability. It also offers tools for tracking and monitoring organization data.
Key facts about Orgvue
- Founded Year: 2005
- Location: London (United Kingdom)
- Annual Revenue: £34M as on Mar 31, 2022
- Stage: Late Stage
- Total Funding till date: $56.4M
- Employee Count: 266 as on Jan 31, 2022
- Investors: Notion, One Peak and 16 Others
- Latest Funding Round: PE, May 01, 2018, $*****
3. Novalia
Developer of printed touch sensor technology for interactive surfaces. This technology adds touch activation, wireless connectivity, and data capture capabilities to printed materials. It combines printed conductive ink sensors with microcontrollers and communication technologies like Bluetooth to create interactive products. The resulting solutions seamlessly blend the digital and physical worlds, enabling innovative applications across various industries. The technology allows for the creation of touch-sensitive surfaces that transform ordinary objects into smart, interactive platforms.
Key facts about Novalia
- Founded Year: 2006
- Location: Cambridge (United Kingdom)
- Stage: Funding Raised
- Employee Count: 7 as on Sep 30, 2022
- Investors: Techstars, Alexa Fund and 3 Others
- Latest Funding Round: Grant (prize money), Oct 01, 2020, $*****
4. Xceleron
Xceleron is an analytical CRO which uses AMS (Accelerated Mass Spectrometry) detection technology to develop pharmaceutical products more quickly and less expensively both at the preclinical and clinical stage. Xceleron claims to have pioneered the use of Carbon 14 Microtracer and AMS for drug validation. The sensitivity of AMS enables very small samples to be analysed – a few µL or mg and even down to a few thousand cells. The technique has been most widely used for Proof of Concept Studies in Phase I for Obtaining human absolute bioavailability data, Gaining vital PK data on high potency drugs, and for Quantifying drug distribution in target tissues such as biopsy samples, cerebral spinal fluid or skin blisters. Through this technique, the company claims the time for analytical MD & MV can be reduced. The company claims that 6 out of 23 drugs approved by FDA in 2013 used AMS data in filing. The company was acquired by Pharmaron, a Chinese CRO offering a suite of preclinical and clinical development services in January 2017.
Key facts about Xceleron
- Founded Year: 1997
- Location: Germantown (United States)
- Stage: Acquired
- Total Funding till date: $10M
- Employee Count: 11 - 50 as on Jul 01, 2024
- Investors: Albion Capital Group, Frog Capital and 4 Others
- Latest Funding Round: Series C, Feb 06, 2012, $*****
- Highlight: Acquired
5. Prosonix
Prosonix is a speciality pharmaceutical company developing a portfolio of inhaled respiratory medicines by design. Pipeline include: PSX1001/PSX1050, a potent inhaled corticosteroid monotherapy for asthma and chronic obstructive pulmonary disease (COPD) in pressurised metered dose inhaler (pMDI); PSX1002, a long-acting muscarinic antagonist for COPD in pMDI; PSX2005 for asthma, SX2000 Novel combination medicines designed specifically for respiratory diseases based on Multi-component Particles (MCPs)
Key facts about Prosonix
- Founded Year: 2006
- Location: Oxford (United Kingdom)
- Stage: Acquired
- Total Funding till date: $27M
- Employee Count: 32 as on Dec 31, 2021
- Investors: Gilde Healthcare, Quest for Growth and 4 Others
- Latest Funding Round: Series B, May 21, 2012, $*****
- Highlight: Acquired
Solon Ventures' Investments by Stage
Solon Ventures has made 2 investments in Series A stage with an average round size of $1.97M, 1 investment in PE stage, 1 investment in Series B stage with an average round size of $12M and 1 investment in Series C stage.Stage of entry | No. of Investments |
|---|---|
Series A | 2 |
PE | 1 |
Series B | 1 |
Series C | 1 |
Note: We have considered here, only first round of investments
Solon Ventures' Investments by Sector
Solon Ventures has a diverse portfolio, with companies operating in the Enterprise Applications, Healthcare, Life Sciences, Consumer and Media & Entertainment. Notably, it has invested in 5 Enterprise (B2B) companies, 5 Tech companies, 3 Consumer (B2C) companies and at least 2 companies focusing on Saas.Sector | No. of Investments |
|---|---|
Enterprise Applications | 2 |
Healthcare | 2 |
Life Sciences | 2 |
Consumer | 1 |
Media & Entertainment | 1 |
Others | 1 |
Note: We have considered here, only first round of investments
Solon Ventures' Investments by Geography
Solon Ventures has made most investments in United Kingdom (3), followed by United States where it has made 2 investments.Country | No. of Investments |
|---|---|
United Kingdom | 3 |
United States | 2 |
Note: We have considered here, only first round of investments
Solon Ventures' recent investments
Solon Ventures has not made any investment in 2026 so far.Here are the most recent investments by Solon Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Nov 16, 2015 | United States | Series B | 2162 | [+2] | |
Jun 15, 2012 | United Kingdom | PE | 9753 | - | |
May 21, 2012 | United Kingdom | Series B | 3073 | [+4] | |
Feb 06, 2012 | United States | Series C | 7073 | ||
Jan 19, 2010 | United States | Series C | 3196 | [+1] |
Unicorns in Solon Ventures' Portfolio
Solon Ventures has 1 unicorn in its portfolio - Fever. The most recent unicorn in their portfolio is Fever which became a unicorn in 2022, 6 years after Solon Ventures first invested in it.Here is a list of unicorns in Solon Ventures' portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
77 | Operator of a platform for booking tickets to various events | 2014 | New York City | Series E | xgrswio |
Acquired companies in Solon Ventures' Portfolio
5 companies from Solon Ventures' portfolio have been acquired. The most recent acquisition were Xceleron in Jan 2017 by Pharmaron.Here are Solon Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 10, 2017 | Jan 19, 2010 | Series C | 9929 | |
May 18, 2015 | Dec 2007 | Series A | 2121 | |
Jul 06, 2014 | Jan 09, 2008 | Series A | 1493 | |
Sep 04, 2012 | - | - | 6872 | |
Aug 30, 2011 | - | - | 1618 |
Team profile of Solon Ventures
Solon Ventures has a team of 2 members including 2 Partners located in United Kingdom. Solon Ventures' team does not sit on the board of any company as of now.Co-investors of Solon Ventures
Over the past 19 years, 31 investors have co-invested in Solon Ventures's portfolio companies. This includes funds and angels.
- Invested before Solon Ventures: Accel, Fidelity Investments and 4 others have invested in rounds before Solon Ventures. There is 1 company where Accel has invested before Solon Ventures and 1 company where Fidelity Investments has invested before Solon Ventures.
- Top Co-investors of Solon Ventures: 2 investors entered a company along with Solon Ventures. These include investors like Frog Capital (1 company).
- Invested after Solon Ventures: A total of 23 investors have invested in Solon Ventures's portfolio after their investments. Top Investors include Rakuten Capital (1 company), ATRESMEDIA (1 company) and Michael Zeisser (1 company).
Recent News related to Solon Ventures
•
Fever closes $12M Series B led by Accel Partners, Fidelity and 14W VenturesNovobrief•Nov 24, 2015•Fever, Accel, Fidelity Investments, 14W and 1 other
•
Prosonix Raised £17.1M in Series B Equity Financing |FinSMEsFinSMEs•May 24, 2012•Prosonix, Gimv, Entrepreneurs Fund, Quest for Growth and 3 others
•
Peakdale Molecular Announces GBP 1 Million Funding to Support Expansion and GrowthPR Newswire•Jan 09, 2008•Peakdale, Solon Ventures
•
Solon Ventures: Prosonix (Acquired by Circassia Pharmaceuticals)Solon Ventures•Prosonix, Solon Ventures, Gimv, Entrepreneurs Fund and 3 others
•
